Pentamidine Isethionate
- Product NDC
- 13925-522
- 11-digit product format
- 139250522
- Labeler code
- 13925
- Product ID
- 13925-522_d00d85f7-4ea4-4da2-8c13-7ecc598893e6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pentamidine Isethionate
- Dosage form
- INHALANT
- Route
- RESPIRATORY (INHALATION)
- Labeler
- Seton Pharmaceuticals
- Application
- ANDA206667
- Marketing category
- ANDA
- Marketing start
- 2019-10-14
- Substance
- PENTAMIDINE ISETHIONATE
- Active strength
- 300 mg/300mg
- Pharmacologic classes
- Antiprotozoal [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Pentamidine Isethionate
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PENTAMIDINE ISETHIONATE | 300 mg/300mg |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | V2P3K60DA2 |
| Rxcui | 861597 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 13925-522-01 | Pentamidine Isethionate | 300 mg in 1 VIAL | INHALANT | 300 | | 6 |
| 13925-522-01 | Pentamidine Isethionate | 1 in 1 CARTON | INHALANT | 1 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 13925-522 | PENTAMIDINE ISETHIONATE INHALANT [SETON PHARMACEUTICALS] | 6 | Current NDC, Legacy NDC, 2 package rows | 20250410_c484f16e-9d97-4416-84a4-8ad8deaf5e19.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 13925-522-01 | 13925052201 | 1 VIAL in 1 CARTON (13925-522-01) / 300 mg in 1 VIAL | 1 vial | 2019-10-14 | 0000-00-00 | No | No | Current |